Kumazawa E - Search Results

1

CM-dextran-polyalcohol-camptothecin conjugate: DE-310 with a novel carrier system and its preclinical data.

Inoue K, Kumazawa E, Kuga H, Susaki H, Masubuchi N, Kajimura T. Inoue K, et al. Among authors: kumazawa e. Adv Exp Med Biol. 2003;519:145-53. doi: 10.1007/0-306-47932-X_9. Adv Exp Med Biol. 2003. PMID: 12675213 No abstract available.

2

A possible mechanism for the long-lasting antitumor effect of the macromolecular conjugate DE-310: mediation by cellular uptake and drug release of its active camptothecin analog DX-8951.

Ochi Y, Shiose Y, Kuga H, Kumazawa E. Ochi Y, et al. Among authors: kumazawa e. Cancer Chemother Pharmacol. 2005 Apr;55(4):323-332. doi: 10.1007/s00280-004-0911-1. Epub 2004 Oct 26. Cancer Chemother Pharmacol. 2005. PMID: 15517271

3

Hyperthermia-enhanced tumor accumulation and antitumor efficacy of a doxorubicin-conjugate with a novel macromolecular carrier system in mice with non-small cell lung cancer.

Oyama T, Kawamura M, Abiko T, Izumi Y, Watanabe M, Kumazawa E, Kuga H, Shiose Y, Kobayashi K. Oyama T, et al. Among authors: kumazawa e. Oncol Rep. 2007 Mar;17(3):653-9. Oncol Rep. 2007. PMID: 17273747

4

DE-310, a novel macromolecular carrier system for the camptothecin analog DX-8951f: potent antitumor activities in various murine tumor models.

Kumazawa E, Ochi Y. Kumazawa E, et al. Cancer Sci. 2004 Feb;95(2):168-75. doi: 10.1111/j.1349-7006.2004.tb03199.x. Cancer Sci. 2004. PMID: 14965368 Free PMC article.

5

Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.

Kumazawa E, Jimbo T, Ochi Y, Tohgo A. Kumazawa E, et al. Cancer Chemother Pharmacol. 1998;42(3):210-20. doi: 10.1007/s002800050807. Cancer Chemother Pharmacol. 1998. PMID: 9685056

6

A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo.

Mitsui I, Kumazawa E, Hirota Y, Aonuma M, Sugimori M, Ohsuki S, Uoto K, Ejima A, Terasawa H, Sato K. Mitsui I, et al. Among authors: kumazawa e. Jpn J Cancer Res. 1995 Aug;86(8):776-82. doi: 10.1111/j.1349-7006.1995.tb02468.x. Jpn J Cancer Res. 1995. PMID: 7559102 Free PMC article.

7

Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.

Takasuna K, Hagiwara T, Watanabe K, Onose S, Yoshida S, Kumazawa E, Nagai E, Kamataki T. Takasuna K, et al. Among authors: kumazawa e. Cancer Chemother Pharmacol. 2006 Oct;58(4):494-503. doi: 10.1007/s00280-006-0187-8. Epub 2006 Jan 25. Cancer Chemother Pharmacol. 2006. PMID: 16437251

8

Antitumour activity of DX-8951f: a new camptothecin derivative.

Kumazawa E, Tohgo A. Kumazawa E, et al. Expert Opin Investig Drugs. 1998 Apr;7(4):625-32. doi: 10.1517/13543784.7.4.625. Expert Opin Investig Drugs. 1998. PMID: 15991999

9

Synthesis and antitumor activity of novel benzophenone derivatives.

Kumazawa E, Hirotani K, Burford SC, Kawagoe K, Miwa T, Mitsui I, Ejima A. Kumazawa E, et al. Chem Pharm Bull (Tokyo). 1997 Sep;45(9):1470-4. doi: 10.1248/cpb.45.1470. Chem Pharm Bull (Tokyo). 1997. PMID: 9331999

10

Synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives.

Naito H, Sugimori M, Mitsui I, Nakamura Y, Iwahana M, Ishii M, Hirotani K, Kumazawa E, Ejima A. Naito H, et al. Among authors: kumazawa e. Chem Pharm Bull (Tokyo). 1999 Dec;47(12):1679-84. doi: 10.1248/cpb.47.1679. Chem Pharm Bull (Tokyo). 1999. PMID: 10748712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters